Infection rapid test 30021000

COVID-19for neutralizing antibodySARS-COV-2

The SARS-CoV-2 antibody Detection Kit(Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in human whole blood, serum, or plasma as an aid in the diagnosis of the presence of neutralizing antibodies to SARS-CoV-2. This COVID-19 Antibody Test Kit is intended for qualitative measurement of neutralizing antibodies in human serum or plasma. SARS-CoV-2 neutralizing antibodies directly target the SARS-CoV-2 S receptor-binding domain (RBD), blocking the protein's interaction with the host ACE2 receptor, thus interfering with the viral attachment to the cell as well as its entry into the cell. When using the reference neutralizing antibody provided in the kit, the assay has a detection range of 9.75-10000 ng/ml, a sensitivity of as low as 9.75 ng/ml, and Intra- /Inter-assay Precision low than 15%. This detection kit is simple in operation and scalable in sample size (high throughput). Multiple validations display it has excellent sensitivity and high specificity. It is conducive to identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. And it should not be used for the diagnosis of acute SARS-CoV-2 infection. The SARS-COV-2 Neutralizing Antibody Rapid Test is intended for the semi-quantitative determination of neutralizing antibodies (NAbs) to SARS-COV-2. It can block the interaction between the receptor binding domain (RBD)of the viral spike glycoprotein with the ACE2 cell surface receptor in human serum, plasma (EDTAand sodium citrate), fingerstick whole blood or venous whole blood specimens.